발행물

전체 논문

129

51

α-Tocotrienol inhibits osteoclastic bone resorption by suppressing RANKL expression and signaling and bone resorbing activity.
Ha H, Lee JH, Kim HN, Lee ZH
Biochem Biophys Res Commun, 2011.03

52

cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
Son J, Lee JH, Kim HN, Ha H, Lee ZH
Biochem Biophys Res Commun, 2010.07

53

Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH*, Jin H*, Shim HE, Kim HN, Ha H, Lee ZH
Mol Pharmacol, 2010

54

Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
Kim HN, Ha H, Lee JH, Jung K, Yang D, Woo KM, Lee ZH
Eur J Pharmacol, 2009.11

55

Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling.
Lee JH, Kim HN, Yang D, Jung K, Kim HM, Kim HH, Ha H, Lee ZH
J Biol Chem, 2009.05

56

Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in Osteoblasts.
Kwak HB, Sun HM, Ha H, Kim HN, Lee JH, Kim HH, Shin HI, Lee ZH
Eur J Pharmacol, 2008.12

57

AG490, a Jak2-specific inhibitor, induces osteoclast survival by activating the Akt and ERK signaling pathways.
Kwak HB, Sun HM, Ha H, Lee JH, Kim HN, Lee ZH
Mol Cells, 2008.11

58

Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis.
Kwak HB, Ha H, Kim HN, Lee JH, Kim HS, Lee S, Kim HM, Kim JY, Kim HH, Song YW, Lee ZH
Arthritis Rheum, 2008.05

59

Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta.
Ha H, Lee JH, Kim HN, Kwak HB, Kim HM, Lee SE, Rhee JH, Kim HH, Lee ZH
J Immunol, 2008.02

60

Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1.
Kwak HB, Yang D, Ha H, Lee JH, Kim HN, Woo ER, Lee S, Kim HH, Lee ZH
Exp Mol Med, 2006.06